天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 66728-98-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 66728-98-1
Chemical Structure| 66728-98-1
Structure of 66728-98-1 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 66728-98-1 ]

Related Doc. of [ 66728-98-1 ]

Alternatived Products of [ 66728-98-1 ]
Product Citations

Product Details of [ 66728-98-1 ]

CAS No. :66728-98-1 MDL No. :MFCD00234469
Formula : C9H5BrClN Boiling Point : -
Linear Structure Formula :- InChI Key :HRWILRGBDZGABZ-UHFFFAOYSA-N
M.W : 242.50 Pubchem ID :459766
Synonyms :

Calculated chemistry of [ 66728-98-1 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 54.45
TPSA : 12.89 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.12 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.34
Log Po/w (XLOGP3) : 3.75
Log Po/w (WLOGP) : 3.65
Log Po/w (MLOGP) : 3.12
Log Po/w (SILICOS-IT) : 3.76
Consensus Log Po/w : 3.32

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.32
Solubility : 0.0115 mg/ml ; 0.0000476 mol/l
Class : Moderately soluble
Log S (Ali) : -3.71
Solubility : 0.0469 mg/ml ; 0.000194 mol/l
Class : Soluble
Log S (SILICOS-IT) : -5.17
Solubility : 0.00162 mg/ml ; 0.00000668 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.66

Safety of [ 66728-98-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 66728-98-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 66728-98-1 ]

[ 66728-98-1 ] Synthesis Path-Downstream   1~12

  • 1
  • [ 98-50-0 ]
  • [ 66728-98-1 ]
  • [4-(4-bromo-[1]isoquinolylamino)-phenyl]-arsonic acid [ No CAS ]
  • 2
  • [ 66728-98-1 ]
  • [ 141-52-6 ]
  • [ 59050-59-8 ]
YieldReaction ConditionsOperation in experiment
98% In 1,4-dioxane; for 1h;Microwave irradiation; Sealed tube; Heating; General procedure: Morpholine (10 mmol), 7-bromo-1-chloroisoquinoline (2 mmol) and 1,4-dioxane (5ml) were dissolved in 10 ml of vial tube. The vial was sealed with a crimp cap and placed in a Biotage initiator microwave cavity. The reaction mixtures were heated 1h at 120 oC. The resulting mixture was evaporated in vacuum. The product was extracted with ethyl acetate. The ethyl acetate layer was dried over anhydrous magnesium sulfate, filtered, and concentrated. The product was purified by silica gel column chromatography using hexane : ethyl acetate = 1:1.7-Bromo-1-(4-morpholinyl)isoqinoline (2a) was obtained in 99 % yield as a brown solid; mp: 129-130; 1H NMR(CDCl3, 300 MHz) delta 8.21 (s, 1H), 8.17 (d, J = 5.7 Hz, 1H), 7.81 (s, 2H), 7.47 - 7.35 (m, 2H), 7.29 (d, J = 5.6 Hz, 1H), 7.10 (t, J = 8.7 Hz, 1H), 4.05 - 3.91 (m, 7H), 3.45 (t, 4H); 13C NMR (75 MHz, CDCl3) delta 160.3, 141.2, 136.6, 133.2, 129.0, 127.8, 122.8, 119.9, 115.9, 67.0, 51.9; MS(m/z) : 293.17 (M+1). The following compounds (2b-f) were prepared with general procedure for nucleophlic substitution of 1-chloro-4 or 7-bromoisoquinoline.
  • 4
  • [ 3749-21-1 ]
  • [ 66728-98-1 ]
YieldReaction ConditionsOperation in experiment
72% With trichlorophosphate; In chloroform; at 0 - 20℃; for 1.5h;Heating / reflux; 2d) 4-BROMO-1-CHLORO-ISOQUINOLINE To a solution of 4-bromoisoquinoline (52. 08 g, 0. 250 MOL) in methylene chloride (600 mL) is added m-chloroperbenzoic acid (64.47 g, 0.250 MOL). The mixture is stirred for 2.5 hours. To the mixture is added 1.5 g of m-chloroperbenzoic acid and the mixture is stirred for 30 minutes. The solution is washed with 1 N NAOH, brine, and then dried over sodium sulfate. The solvent is removed to give a white solid. The solid is crystallized from hot acetone to yield 32.22 g (57.6%) of a white SOLID. 1H, 13C NMR consistent with structure. The N-oxide (15.75 g, 0.0703 mol) is dissolved in chloroform (50 mL) and cooled in an ice bath. Phosphorus OXYCHLORIDE (20 mL) is added dropwise and then the mixure is warmed to room temperature and then heated to reflux for 1.5 hours. The mixture is allowed to cool to room temperature and is then poured over ice. The aqueous mixture is neutralized to pH 7-8 with NAHCO3 AND then extracted with chloroform. The organic phase is washed with brine, dried over sodium sulfate and the solvent is removed. The residue is purified by flash chromatography (SIO2/5% ETHYL acetate/hexanes). Collected 12.22 g (72%). M+H = 389. 'H NMR ; 5 8. 50 (s, 1H), 8.40 (d, 1H), 8.20 (d, 1H), 7.92 (t, 1H), 7.79 (t, 1H).
52% With trichlorophosphate; In dichloromethane; N,N-dimethyl-formamide; at 0 - 25℃;Inert atmosphere; General procedure: To a stirred solution of the appropriate azine N-oxides in anhydrous CH2Cl2 (0.1M) at 0 C is added POCl3 (1.2 equiv) followed by dropwise addition of DMF (0.5 equiv) under argon. The resulting reaction mixture was warmed to 25 C and stirred for several hours until the reaction is complete as indicated by TLC. Saturated aqueous sodium carbonate solution is added to the reaction mixture slowly to adjust the pH to 7~8. The resulting mixture is separated and the aqueous phase is extracted with CH2Cl2 thoroughly. The organic phase is combined and washed with brine, dried over Na2SO4, filtered and concentrated under reduced pressure to afford the crude product, which is purified by flash column chromatography using PE/EA (80:1) as eluent.
With sodium hydrogencarbonate; trichlorophosphate; In dichloromethane; 1,2-dichloro-ethane; (b) A yellow suspension of 4-bromoisoquinoline N-oxide, P-1a, (6.9 g, 30.8 mmol. 1.0 eq) in 1,2-dichloroethane (60 mL) was treated with phosphorus oxychloride (Aldrich, 9.0 mL, 96.4 mmol, 1.8 eq) and warmed to 80 C. After 1.5 hours, the resultant green suspension was carefully poured into a cold solution of 50% saturated sodium bicarbonate (500 mL) and the aqueous layer was extracted with diethyl ether (3*300 mL). The combined organic extracts were washed with water (200 mL), brine (200 mL), dried over magnesium sulfate, and concentrated under reduced pressure to give a tan solid (6.8 g). The crude product was dissolved in a minimal amount of dichloromethane and purified by flash chromatography over silica gel using 5% ether/cyclohexane to give 4-bromo-1-chloro-isoquinoline, P-1b, as a white solid (5.7 g, 77%): HPLC Rf=15.4 min.; TLC Rf=0.4 (5% ether/cyclohexane); 1H NMR (300 MHz, DMSO-d6) delta8.68 (s, 1H), 8.42 (d, 1H, J=8.4 Hz), 8.26 (d, 1H, J=8.3 Hz), 8.15 (t, 1H, J=7.6 Hz), 8.02 (t, 1H, J=7.6 Hz); 13C NMR (75 MHz, DMSO-d6) delta150.4, 143.0, 135.8, 133.8, 130.8, 127.3, 126.8, 126.5, 119.0; MS (ESI) m/z 242/244 [M+H]+.
115 mg With trichlorophosphate; In N,N-dimethyl-formamide; toluene; at 20℃;Inert atmosphere; Cooling with ice; 4-Bromoisoquinoline (34) (200 mg, 0.961 mmol), Na2WO4·H2O (32 mg, 0.096 mmol), AcOH (5 ml) and 30% H2O2 (297 mul, 88 mmol) were added in the reaction flask and the mixture was stirred at 80 C for 3 h. After cooling 50 ml of CH2Cl2 was added and the organic phase washed with saturated NaHCO3 and water. After drying the organic phase with anhydrous Na2SO4 and removal of the solvent under vacuum, 240 mg of crude N-oxide 35 was obtained. The crude 35 was dissolved in mixture of dimethylformamide (1.5 ml) and toluene (4.5 ml) and phosphorus oxychloride (176 mul, 1.92 mmol,) was added in ice cooled reaction mixture under argon. The reaction mixture was stirred at rt for 1 h and then partitioned between EtOAc and water. The organic layer was washed with saturated NaHCO3 (twice), water, dried over anhydrous Na2SO4, and solvent removed under vacuum. The residue (270 mg) was purified by silica gel flash chromatography (2.5% EtOAc-petroleum ether) to give 115 mg (total yield 49%) of 36 as a white solid. 1H NMR (CDCl3): delta 8.48 (s, 1H); 8.35 (d, 1H, J = 8.5 Hz); 8.20 (d, 1H, J = 8.5 Hz); 7.87 (t, 1H, J = 7.6 Hz); 7.77 (t, 1H, J = 7.6 Hz).

  • 5
  • [ 19493-44-8 ]
  • [ 66728-98-1 ]
  • 6
  • [ 917-64-6 ]
  • [ 66728-98-1 ]
  • [ 104704-40-7 ]
  • 7
  • [ 66728-98-1 ]
  • [ 50-01-1 ]
  • <i>N</i>-(4-bromo-isoquinolin-1-yl)-guanidine [ No CAS ]
  • 8
  • [ 3951-95-9 ]
  • [ 66728-98-1 ]
  • 9
  • [ 66728-98-1 ]
  • [ 124-41-4 ]
  • 4-bromo-1-methoxyisoqionoline [ No CAS ]
YieldReaction ConditionsOperation in experiment
88% In methanol; at 70℃; Example I 4-BROMO-1-METHOXYISOQUINOLINE A solution of 0. 5 g (2. 1 mmol) <strong>[66728-98-1]4-bromo-1-chloroisoquinoline</strong> in 10 mL (5 mmol) 0. 5 M sodium methoxide in methanol was heated to 70 C for overnight with stirring, then cooled to a4mbient temperature and diluted with 30 mL water to produce copious white precipitate. The mixture was cooled to 0 C for 60 minutes, then filtered, washed with water, and air-dried to produce 0. 44 g (1. 8 mmol, 88%) of the title compound as a white, waxy solid. 1H-NMR (300 MHz, CDC13, 6) : 8. 25 (D, J = 8 Hz, 1H), 8. 18 (s, 1H), 8. 06 (d, J= 8 Hz, 1H), 7. 78 (td, J= 1 Hz, 7 Hz, 1H), 7. 60 (td, J= 1 Hz, 7 Hz, 1H), 4. 12 (s, 3H) ; m/z : 239 [M+H] +.
  • 10
  • [ 66728-98-1 ]
  • [ 83889-38-7 ]
  • 11
  • [ 66728-98-1 ]
  • [ 104704-41-8 ]
  • 12
  • [ 66728-98-1 ]
  • [ 104704-42-9 ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 66728-98-1 ]

Bromides

Chemical Structure| 1245647-25-9

[ 1245647-25-9 ]

5-Bromo-1-chloro-6-methylisoquinoline

Similarity: 0.89

Chemical Structure| 1233025-78-9

[ 1233025-78-9 ]

8-Bromo-1-chloroisoquinoline

Similarity: 0.87

Chemical Structure| 215453-51-3

[ 215453-51-3 ]

7-Bromo-1-chloroisoquinoline

Similarity: 0.85

Chemical Structure| 29241-60-9

[ 29241-60-9 ]

5-Bromo-2-chloro-3-methylpyridine

Similarity: 0.82

Chemical Structure| 778611-64-6

[ 778611-64-6 ]

5-Bromo-2-chloro-4-methylpyridine

Similarity: 0.82

Chlorides

Chemical Structure| 1245647-25-9

[ 1245647-25-9 ]

5-Bromo-1-chloro-6-methylisoquinoline

Similarity: 0.89

Chemical Structure| 1233025-78-9

[ 1233025-78-9 ]

8-Bromo-1-chloroisoquinoline

Similarity: 0.87

Chemical Structure| 215453-51-3

[ 215453-51-3 ]

7-Bromo-1-chloroisoquinoline

Similarity: 0.85

Chemical Structure| 29241-60-9

[ 29241-60-9 ]

5-Bromo-2-chloro-3-methylpyridine

Similarity: 0.82

Chemical Structure| 778611-64-6

[ 778611-64-6 ]

5-Bromo-2-chloro-4-methylpyridine

Similarity: 0.82

Related Parent Nucleus of
[ 66728-98-1 ]

Isoquinolines

Chemical Structure| 1245647-25-9

[ 1245647-25-9 ]

5-Bromo-1-chloro-6-methylisoquinoline

Similarity: 0.89

Chemical Structure| 1233025-78-9

[ 1233025-78-9 ]

8-Bromo-1-chloroisoquinoline

Similarity: 0.87

Chemical Structure| 215453-51-3

[ 215453-51-3 ]

7-Bromo-1-chloroisoquinoline

Similarity: 0.85

Chemical Structure| 205055-63-6

[ 205055-63-6 ]

6-Bromo-1-chloroisoquinoline

Similarity: 0.79

Chemical Structure| 1204298-52-1

[ 1204298-52-1 ]

4-Bromo-6-methylisoquinoline

Similarity: 0.77

; ;